The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.

The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.

A label-free approach to distinguish the proliferative and apoptotic features of glioma cells by using terahertz metamaterials with large effective area is proposed. Various frequency-shift responses ...

Glioblastoma (GBM) is the most common adult primary brain tumor. Despite aggressive multimodal therapy, the survival of patients with GBM remains dismal. However, recent evidence has demonstrated the ...

It has been over 60 years since Osamu Shimomura et al. discovered Green Fluorescent Protein (GFP)1. Since then, the color ...

Differ from these instrumental techniques, fluorescent probe techniques attract tremendous attentions because of simple operation process, rapid response and high sensitivity for metal ions sensing [8 ...

Accurate diagnosis and highly effective treatment of glioblastoma are still challenges in clinic. Near-infrared (NIR) light triggered fluorescence imaging and photodynamic therapy (PDT) showed the ...

Methods: Relevant articles on glioma drug therapy were retrieved from the Web of Science Core Collection for the period 2020–2024. Bibliometric analyses were performed using CiteSpace and VOSviewer to ...